Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Hamamoto

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Cancer Science|December 5, 2020
Prospective evaluation and refinement of an S-1 dosage formula based on renal function for clinical applicationMasashi Takeuchi, Chiyo K Imamura, Eisuke Booka, et al.
BMC Cancer|July 19, 2024
Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (PARADISE-1): a phase I trialKenro Hirata, Kayo Yoshida, Chikatoshi Katada, et al.
Cancer Management and Research|July 2, 2020
Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid TumorsKeitaro Shimozaki, Yasutaka Sukawa, Noriko Beppu, et al.
Cancer Science|March 12, 2020
Long-term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancerKen Kato, Yuichiro Doki, Takashi Ura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[A case report of conversion therapy for initially unresectable colorectal cancer liver metastases after cetuximab as third-line treatment]Yasuo Hamamoto, Tomomi Komaki, Junko Miyamoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 25, 2012
Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cellsHideko Akagi, Hajime Higuchi, Hidetoshi Sumimoto, et al.
Cancer Science|January 24, 2015
Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancerShuhei Mayanagi, Minoru Kitago, Toshiharu Sakurai, et al.
The Oncologist|June 22, 2014
Quality of life in the trastuzumab for gastric cancer trialTaroh Satoh, Yung-Jue Bang, Evgeny A Gotovkin, et al.
The Lancet. Oncology|March 19, 2017
Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trialToshihiro Kudo, Yasuo Hamamoto, Ken Kato, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 20, 2011
Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) studyAkira Sawaki, Yasuo Ohashi, Yasushi Omuro, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Cancer Science|December 5, 2020
Prospective evaluation and refinement of an S-1 dosage formula based on renal function for clinical applicationMasashi Takeuchi, Chiyo K Imamura, Eisuke Booka, et al.
BMC Cancer|July 19, 2024
Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (PARADISE-1): a phase I trialKenro Hirata, Kayo Yoshida, Chikatoshi Katada, et al.
Cancer Management and Research|July 2, 2020
Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid TumorsKeitaro Shimozaki, Yasutaka Sukawa, Noriko Beppu, et al.
Cancer Science|March 12, 2020
Long-term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancerKen Kato, Yuichiro Doki, Takashi Ura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[A case report of conversion therapy for initially unresectable colorectal cancer liver metastases after cetuximab as third-line treatment]Yasuo Hamamoto, Tomomi Komaki, Junko Miyamoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 25, 2012
Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cellsHideko Akagi, Hajime Higuchi, Hidetoshi Sumimoto, et al.
Cancer Science|January 24, 2015
Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancerShuhei Mayanagi, Minoru Kitago, Toshiharu Sakurai, et al.
The Oncologist|June 22, 2014
Quality of life in the trastuzumab for gastric cancer trialTaroh Satoh, Yung-Jue Bang, Evgeny A Gotovkin, et al.
The Lancet. Oncology|March 19, 2017
Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trialToshihiro Kudo, Yasuo Hamamoto, Ken Kato, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 20, 2011
Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) studyAkira Sawaki, Yasuo Ohashi, Yasushi Omuro, et al.
Pageof 13